Butta Nora, Román María Teresa Álvarez
Coagulopathies and Disorders of Haemostasis Group, IdiPAZ-Hospital Universitario La Paz, Madrid, Spain.
Universidad Autónoma de Madrid, Madrid, Spain.
Br J Haematol. 2025 Jan;206(1):378-379. doi: 10.1111/bjh.19876. Epub 2024 Oct 29.
There are no clear indicators to predict the outcome of patients with immune thrombocytopenia or the response to drugs. The work of Durand et al. shows that Indium-111 platelet scintigraphy is useful in identifying those patients who will benefit from splenectomy and lays the groundwork for studies demonstrating the increased corticosteroid dependency and rituximab refractoriness of the hepatic platelet sequestration group. Commentary on: Durand et al. Course of immune thrombocytopenia according to the site of platelet destruction identified by indium-111 platelet scintigraphy. Br J Haematol 2025; 206:279-289.
目前尚无明确指标可预测免疫性血小板减少症患者的预后或对药物的反应。杜兰德等人的研究表明,铟-111血小板闪烁扫描术有助于识别那些将从脾切除术中获益的患者,并为证明肝血小板滞留组皮质类固醇依赖性增加和利妥昔单抗难治性的研究奠定了基础。评论文章:杜兰德等人。根据铟-111血小板闪烁扫描术确定的血小板破坏部位分析免疫性血小板减少症的病程。《英国血液学杂志》2025年;206:279 - 289。